Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Blood|March 3, 2016
Randomized multicenter phase 2 study of pomalidomide, cyclophosphamide, and dexamethasone in relapsed refractory myelomaRachid C Baz, Thomas G Martin, Hui-Yi Lin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2011
Antimyeloma activity of a multitargeted kinase inhibitor, AT9283, via potent Aurora kinase and STAT3 inhibition either alone or in combination with lenalidomideLoredana Santo, Teru Hideshima, Diana Cirstea, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2019
Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple MyelomaSagar Lonial, Susanna Jacobus, Rafael Fonseca, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 18, 2013
Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myelomaAyman Saad, Anuj Mahindra, Mei-Jie Zhang, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 4, 2015
New cancers after autotransplantations for multiple myelomaAnuj Mahindra, Girindra Raval, Paulette Mehta, et al.Bone Marrow Transplantation|January 19, 2018
Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMTDavid Buchbinder, Debra Lynch Kelly, Rafael F Duarte, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 24, 2017
Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow TransplantationDebra Lynch Kelly, David Buchbinder, Rafael F Duarte, et al.Journal for Immunotherapy of Cancer|December 27, 2016
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemiaMichael Boyiadzis, Michael R Bishop, Rafat Abonour, et al.Leukemia Research|July 30, 2018
Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myelomaTomas Radivoyevitch, Robert M Dean, Bronwen E Shaw, et al.Pageof 3